Randomized Clinical Trial
Copyright ©The Author(s) 2024.
World J Psychiatry. Oct 19, 2024; 14(10): 1521-1537
Published online Oct 19, 2024. doi: 10.5498/wjp.v14.i10.1521
Table 5 Levels of discrimination - Everyday Discrimination Scale
Outcome measures
Sample groups
Baseline
One-month
P value
Effectiveness size
Power
Item 1VR (n = 23), mean (SD)4.29 (1.27)4.13 (1.29)0.620.06770.9998
TAU (n = 17), mean (SD)3.71 (1.52)4.12 (1.54)0.4540.1250.9784
VR vs TAU1--0.9240.01550.9995
Item 2VR (n = 23), mean (SD)32.17 (4.13)31.78 (4.31)0.5310.08330.9996
TAU (n = 17), mean (SD)31.14 (3.73)32.83 (4.75)0.1470.2370.7974
VR vs TAU1--0.3670.1430.9717
Item 3VR (n = 23), mean (SD)5.53 (0.71)5.08 (10.4)0.1520.2130.9575
TAU (n = 17), mean (SD)5.43 (10.3)5.47 (0.80)0.9180.01980.9992
VR vs TAU1--0.2860.1870.9236
Item 4VR (n = 23), mean (SD)4.79 (1.07)4.78 (1.24)0.9090.01571
TAU (n = 17), mean (SD)5.14 (1.03)5.06 (1.03)0.7250.06190.9964
VR vs TAU1--0.5470.10.9912
Item 5VR (n = 23), mean (SD)5.35 (0.88)5.09 (1.08)0.3750.1290.9974
TAU (n = 17), mean (SD)4.71 (1.74)5.06 (1.43)0.6280.08640.9925
VR vs TAU1--0.6920.06780.9967
Item 6VR (n = 23), mean (SD)5.62 (0.70)5.30 (0.97)0.2160.1920.9768
TAU (n = 17), mean (SD)5.71 (0.56)5.59 (0.71)0.7140.07730.9943
VR vs TAU1--0.3590.1660.9513
Item 7VR (n = 23), mean (SD)4.88 (0.98)4.43 (1.34)0.2510.1570.9927
TAU (n = 17), mean (SD)4.29 (0.90)4.35 (0.86)0.860.03060.9988
VR vs TAU1--0.7530.05170.9981
Item 8VR (n = 23), mean (SD)5.06 (1.37)5.17 (1.11)0.9810.00361
TAU (n = 17), mean (SD)4.29 (1.79)4.06 (1.60)0.5670.0950.9904
VR vs TAU1--0.0230.3750.2722
Item 9VR (n = 23), mean (SD)5.09 (1.22)5.13 (1.14)0.9870.00241
TAU (n = 17), mean (SD)3.71 (1.79)4.18 (1.51)0.4450.1260.9778
VR vs TAU1--0.040.3390.4144